Key result
A 40-year-old woman with primary cardiac natural killer/T cell lymphoma treated with three cycles of chemotherapy ultimately died of multiple organ failure.
Why the study?
Primary cardiac lymphoma is an extremely rare malignancy and optimal treatment strategies have not been fully defined.
Case Report (n=1)
Highlights poor prognosis in rare primary cardiac NK/T-cell lymphoma; leaves open optimal treatment strategies.
Primary cardiac lymphoma is an extremely rare malignancy, which is typically of a non-Hodgkin's type. Clinical manifestations including dyspnea, arrhythmia, chest pain and so on, may vary according to heart site involved and the right atrium is most frequently involved. Histologically, the majority of primary cardiac lymphomas are B-cell origin, especially diffuse large B-cell lymphoma. Here we report a case of primary cardiac nature killer/T cell lymphoma arising in a 40-year-old woman, who presented with paroxysmal chest congestion, nausea and ventricular tachycardia, and diagnosed by open chest surgery and whole body PET/CT scan, then treated with three cycles of chemotherapy, but finally died of multiple organ failure. The optimal treatment strategies to primary cardiac lymphoma have not been fully defined due to its rarity, which still needs to gather more cases and conduct further researches.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2020) conducted a case report in Primary cardiac natural killer/T cell lymphoma (n=1). Chemotherapy was evaluated. A 40-year-old woman with primary cardiac natural killer/T cell lymphoma treated with three cycles of chemotherapy ultimately died of multiple organ failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: